Consensus stability among composite decision makers in the framework of hesitant fuzzy graph model with application to doctor-patient disputes.

Journal: Scientific reports
Published Date:

Abstract

Doctor-patient disputes are inevitable in human beings' social lives. The rapid development of social media makes doctor-patient disputes easier to spiral out of control. One of the ensuing problems is that the size of the parties in conflict has increased, and conflicts between individuals are more easily transformed into conflicts between groups and organizations. Thus, a new concept called composite decision-makers (CDMs) that represent a set of stakeholders or organizations with common interest goals is proposed in the graph model for conflict resolution (GMCR) with hesitant fuzzy preference relations (HFPRs). To be specific, first, this research uses HFPRs to represent the preferences of individuals within a group, and thereby defines a consensus measurement method based on grey relational analysis. Then, the K-means clustering method is improved based on social trust network and grey relational analysis. Next, based on the clustering results and consensus measures, a DeGroot opinion evolution model is proposed to simulate the interaction of opinions between subgroups. The above described method can be used to reach consensus among CDMs and thereby obtain a preference ranking over all states for CDMs for carrying out conflict analysis. CDMs' HFPRs has been transformed to be group preferences that are represented by fuzzy preferences. Crucially, a set of novel consensus stability definitions among CDMs is proposed in the hesitant fuzzy graph model structure. Finally, the new proposed stability definitions are applied to doctor-patients disputes in China to assist the government in promoting reconciliation between doctors and patients to enhance social harmony.

Authors

  • Tianming Zhang
    College of Business, Yancheng Teachers University, Yancheng, 224007, People's Republic of China.
  • Dayong Wang
    BeckLab, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Yejun Xu